Needham analyst Rajvindra Gill reiterates Microchip Technology (NASDAQ:MCHP) with a Buy and maintains $110 price target.
BMO Capital Markets Says 4D Molecular Could Be ‘Attractive Acquisition Target’
BMO Capital Markets initiated coverage on 4D Molecular Therapeutics Inc (NASDAQ:FDMT) with an Outperform rating and a price target of $50. The…